Remove Medicine Remove Radiology Remove Scientist
article thumbnail

Advancing and Safeguarding Clinical Research for a Better Tomorrow

Advarra

Furthermore, Advarras IRB includes hundreds of expert members, many of whom bring expertise and experience in several therapeutic areas and disciplines, including oncology, bioethics, investigational pharmacy, internal medicine, psychology, physiology, radiology, public health, pediatrics, nursing, and social and behavioral science.

article thumbnail

World Cancer Day 2024: Trends in Oncology Research and More

XTalks

Personalized medicine: One of the most exciting prospects of CRISPR/Cas9 in oncology is its contribution to personalized medicine. For example, a study published in Nature Medicine in 2020 reported on the safety and feasibility of using CRISPR-edited T cells in patients with refractory non-small-cell lung cancer (NSCLC).

Research 118
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

C-Path announces SHIP-MD 2021 Virtual Workshop

Scienmag

Food and Drug Administration’s (FDA) Center for Devices and Radiological Health (CDRH) AdvaMed, the American Academy of Pediatrics (AAP) and multiple pediatric health system leaders, is […]. Multi-stakeholder event will focus on national innovation ecosystem for pediatric medical device development TUCSON, Ariz.,

article thumbnail

Power to the Patient with Patient Generated Health Data

FDA Law Blog

Lenz, Principal Medical Device Regulation Expert — FDA’s Center for Devices and Radiological Health (CDRH) recently partnered with the Digital Medicine Society (DiMe) to host a two-day workshop to help advance the use of patient-generated health data (PGHD) to support improved clinical trials, medical device development, and regulatory science.

article thumbnail

Behind the Breakthroughs and Practice-Changing Advances: Insights from ESMO 2024

Intouch Solutions

Biomarkers: The data and insights around precision oncology and personalized medicine continue to grow at an incredible pace. And that’s really exciting because that means our response rates are gonna go up and patients are really getting that sense of personalized medicine. I have seen quite a few excited scientists, I must admit.

DNA 59
article thumbnail

Low-dose radiotherapy combined with immunotherapy eradicates metastatic cancer in mice

Bioengineer

associate professor of human oncology in the University of Wisconsin School of Medicine and Public Health, and their colleagues designed a study to give mice with immunologically cold metastatic cancers varying doses of targeted radionuclide therapy alongside immunotherapy. About the University of Pittsburgh School of Medicine.

article thumbnail

Cooking with Wood May Cause Lung Damage

The Pharma Data

a postdoctoral researcher from the University of California San Diego School of Medicine. RSNA is an association of radiologists, radiation oncologists, medical physicists and related scientists promoting excellence in patient care and health care delivery through education, research and technologic innovation. OAK BROOK, Ill. ,